Back
InflaRx NV Stock Price Chart
Sell
33
IFRX
InflaRx NV
Last Price:
1.46
Seasonality Move:
-21.05%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and IFRX is experiencing slight buying pressure.
InflaRx NV Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.52 | Sell |
20-day SMA: | 1.39 | Buy |
50-day SMA: | 1.44 | Buy |
200-day SMA: | 1.96 | Sell |
8-day EMA: | 1.47 | Sell |
20-day EMA: | 1.43 | Buy |
50-day EMA: | 1.45 | Sell |
200-day EMA: | 1.92 | Sell |
InflaRx NV Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 51.23 | Buy |
Chaikin Money Flow: | 21243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.27 - 1.51) | Buy |
Bollinger Bands (100): | (1.39 - 1.71) | Sell |
InflaRx NV Technical Analysis
May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for InflaRx NV Stock
Is InflaRx NV Stock a Buy?
- InflaRx NV share price is 1.45 while IFRX 8-day simple moving average is 1.52, which is a Sell signal.
- The stock price of IFRX is 1.45 while InflaRx NV 20-day SMA is 1.39, which makes it a Buy.
- InflaRx NV 50-day simple moving average is 1.44 while IFRX share price is 1.45, making it a Buy technically.
- IFRX stock price is 1.45 and InflaRx NV 200-day simple moving average is 1.96, creating a Sell signal.
IFRX Technical Analysis vs Fundamental Analysis
Sell
33
InflaRx NV (IFRX)
is a Sell
Is InflaRx NV a Buy or a Sell?
-
InflaRx NV stock is rated a Sell
The current InflaRx NV [IFRX] share price is $1.45. The Score for IFRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
InflaRx NV Stock Info
Market Cap:
85.38M
Price in USD:
1.45
Share Volume:
191.19K
InflaRx NV 52-Week Range
52-Week High:
4.70
52-Week Low:
1.14
Sell
33
InflaRx NV (IFRX)
is a Sell
InflaRx NV Share Price Forecast
-
What is the InflaRx NV stock price today?
The InflaRx NV stock price is 1.45 USD today. -
Will IFRX stock go up or go down?
InflaRx NV> share price is forecast to RISE/FALL based on technical indicators -
Is InflaRx NV overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, InflaRx NV is overvalued.
Is InflaRx NV Stock a Buy?
- InflaRx NV share price is 1.45 while IFRX 8-day exponential moving average is 1.47, which is a Sell signal.
- The stock price of IFRX is 1.45 while InflaRx NV 20-day EMA is 1.43, which makes it a Buy.
- InflaRx NV 50-day exponential moving average is 1.45 while IFRX share price is 1.45, making it a Sell technically.
- IFRX stock price is 1.45 and InflaRx NV 200-day simple moving average is 1.92, creating a Sell signal.
Fundamental Analysis of InflaRx NV
Is InflaRx NV a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.13 per share.
Technical Analysis of InflaRx NV
Should I short InflaRx NV stock?
- IFRX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting InflaRx NV is a Buy
- InflaRx NV Relative Strength Index (RSI) is 51.23, which suggest InflaRx NV is overbought
- The Bollinger Bands (25) for InflaRx NV is (1.27 - 1.51), which suggest InflaRx NV is a Sell
- The Bollinger Bands (100) for InflaRx NV is (1.39 - 1.71), which suggest InflaRx NV is a Sell
* InflaRx NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.